{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:07:16Z","timestamp":1790186836333,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.amjmed.2014.10.039","type":"journal-article","created":{"date-parts":[[2014,11,18]],"date-time":"2014-11-18T16:28:24Z","timestamp":1416328104000},"page":"403-409","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Cholesterol Treatment and Changes in Guidelines in an Academic Medical Practice"],"prefix":"10.1016","volume":"128","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6388-5553","authenticated-orcid":false,"given":"Martin W.","family":"Schoen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5604-7954","authenticated-orcid":false,"given":"Joanne","family":"Salas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey F.","family":"Scherrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred R.","family":"Buckhold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.amjmed.2014.10.039_bib1","first-page":"1","article-title":"Deaths: preliminary data for 2010","volume":"60","author":"Murphy","year":"2012","journal-title":"Natl Vital Stat Rep"},{"issue":"25 Pt B","key":"10.1016\/j.amjmed.2014.10.039_bib2","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults","volume":"63","author":"Stone","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"19","key":"10.1016\/j.amjmed.2014.10.039_bib3","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Expert panel on detection, evaluation and treatment of high blood cholesterol in adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Adult Treatment Panel (ATP III)","volume":"285","author":"Cleeman","year":"2001","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.amjmed.2014.10.039_bib4","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jacc.2004.07.001","article-title":"Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines","volume":"44","author":"Grundy","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"25 Suppl 2","key":"10.1016\/j.amjmed.2014.10.039_bib5","first-page":"S49","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk: A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"129","author":"Goff","year":"2014","journal-title":"Circulation"},{"issue":"9753","key":"10.1016\/j.amjmed.2014.10.039_bib6","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet"},{"issue":"9907","key":"10.1016\/j.amjmed.2014.10.039_bib7","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1016\/S0140-6736(13)62388-0","article-title":"Statins: new American guidelines for prevention of cardiovascular disease","volume":"382","author":"Ridker","year":"2013","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.amjmed.2014.10.039_bib8","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1001\/jama.2014.2630","article-title":"Validation of the atherosclerotic cardiovascular disease pooled cohort risk equations","volume":"311","author":"Muntner","year":"2014","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.amjmed.2014.10.039_bib9","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1371\/journal.pmed.0020123","article-title":"National trends in statin\u00a0use by coronary heart disease risk category","volume":"2","author":"Ma","year":"2005","journal-title":"PLoS Med"},{"issue":"9","key":"10.1016\/j.amjmed.2014.10.039_bib10","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1345\/aph.1L181","article-title":"Trends in statin use and low-density lipoprotein cholesterol levels among US adults: impact of the 2001 National Cholesterol Education Program guidelines","volume":"42","author":"Mann","year":"2008","journal-title":"Ann Pharmacother"},{"issue":"38","key":"10.1016\/j.amjmed.2014.10.039_bib11","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1093\/eurheartj\/eht295","article-title":"Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences","volume":"34","author":"Chowdhury","year":"2013","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.amjmed.2014.10.039_bib12","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1093\/fampra\/cmr025","article-title":"Physician adherence to the dyslipidemia guidelines is as challenging an issue as patient adherence","volume":"28","author":"Vashitz","year":"2011","journal-title":"Fam Pract"},{"issue":"4","key":"10.1016\/j.amjmed.2014.10.039_bib13","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.amjopharm.2005.12.001","article-title":"The influence of physicians' guideline compliance on patients' statin adherence: a retrospective cohort study","volume":"3","author":"Campione","year":"2005","journal-title":"Am J Geriatr Pharmacother"},{"issue":"15","key":"10.1016\/j.amjmed.2014.10.039_bib14","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1056\/NEJMoa1315665","article-title":"Application of new cholesterol guidelines to a population-based sample","volume":"370","author":"Pencina","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"18","key":"10.1016\/j.amjmed.2014.10.039_bib15","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","article-title":"Prediction of coronary heart disease using risk factor categories","volume":"97","author":"Wilson","year":"1998","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.amjmed.2014.10.039_bib16","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1001\/jama.2013.284657","article-title":"More than a billion people taking statins? Potential implications of the new cardiovascular guidelines","volume":"311","author":"Ioannidis","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.amjmed.2014.10.039_bib17","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0140-6736(86)90597-0","article-title":"Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361,662 men","volume":"2","author":"Martin","year":"1986","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.amjmed.2014.10.039_bib18","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1161\/01.CIR.84.3.1405","article-title":"Ancel Keys Lecture","volume":"84","author":"Rose","year":"1991","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.amjmed.2014.10.039_bib19","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1001\/jama.2013.284203","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol: a fresh interpretation of old evidence","volume":"311","author":"Psaty","year":"2014","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.amjmed.2014.10.039_bib20","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1161\/CIRCULATIONAHA.109.933705","article-title":"Drug therapies for the primary prevention of cardiovascular events: trials and errors: 2009 Ancel Keys Memorial Lecture","volume":"121","author":"Psaty","year":"2010","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.amjmed.2014.10.039_bib21","first-page":"CD004816","article-title":"Statins for the primary prevention of cardiovascular disease","author":"Taylor","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.amjmed.2014.10.039_bib22","doi-asserted-by":"crossref","first-page":"f6989","DOI":"10.1136\/bmj.f6989","article-title":"Majority of panelists on controversial new cholesterol guideline have current or recent ties to drug manufacturers","volume":"347","author":"Lenzer","year":"2013","journal-title":"BMJ"},{"issue":"8","key":"10.1016\/j.amjmed.2014.10.039_bib23","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1001\/archinte.167.8.847","article-title":"Physician follow-up and provider continuity are associated with long-term medication adherence: a study of the dynamics of statin use","volume":"167","author":"Brookhart","year":"2007","journal-title":"Arch Intern Med"},{"issue":"7","key":"10.1016\/j.amjmed.2014.10.039_bib24","doi-asserted-by":"crossref","first-page":"526","DOI":"10.7326\/0003-4819-158-7-201304020-00004","article-title":"Discontinuation of statins in routine care settings: a cohort study","volume":"158","author":"Zhang","year":"2013","journal-title":"Ann Intern Med"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934314010249?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934314010249?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T09:04:19Z","timestamp":1757581459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934314010249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0002934314010249"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2014.10.039","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cholesterol Treatment and Changes in Guidelines in an Academic Medical Practice","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2014.10.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}